Cancer Immunotherapy Reaches A Tipping Point
This article was originally published in Start Up
Executive Summary
Now that it is clear the immune system can kill cancer, all kinds of companies are obsessed with the idea. Start-ups are tailoring business models to divergent technologies and market dynamics.